Thursday, January 19, 2006


Viral Hepatitis C - Indenix is Nearing Phase III for Valopicitabine


Indenix is Nearing Phase III for Valopicitabine
It is always good to see progress with alternatives to current medical therapy for HCV. Even though companies that are working on solutions to be used with interferon are not really offering anything groundbreaking or revolutionary, it does continue the...

VX-950 To Get Fast Tracked
As you may recall we've been saying VX-950 is the revolutionary new therapy to watch for HCV. Now it looks like the FDA agrees this treatment is quite promising and deserving of faster approval than a lesser worthy approach. Another...

Vertex Progresses with VX-950
Vertex is the racehorse to watch right now. They are progressing quicky on their preliminary good results. While it's not yet time to line up for their treatment, we believe theirs will be first to market of the new approaches...

Hepatitis C
Title: Hepatitis CCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Healthy Habits: What Your Doctor Wants You To Know
Title: Healthy Habits: What Your Doctor Wants You To KnowCategory: Doctor's ViewsCreated: 12/9/2005Last Editorial Review: 12/22/2005